Yoshihiro Arai
Amministratore Delegato presso SOLASIA PHARMA K.K.
Patrimonio netto: 190 754 $ in data 30/04/2024
Profilo
Yoshihiro Arai is currently the President, CEO & Representative Director at Solasia Pharma KK since 2013.
Previously, he worked as a Principal at Amgen KK and Searle Yakuhin KK.
He holds an MBA from the University of Wales (Bangor) and has undergraduate and graduate degrees from Tokyo University of Pharmacy & Life Science.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SOLASIA PHARMA KK
0.60% | 31/12/2023 | 1 154 545 ( 0.60% ) | 190 754 $ | 30/04/2024 |
Posizioni attive di Yoshihiro Arai
| Società | Posizione | Inizio |
|---|---|---|
| SOLASIA PHARMA K.K. | Amministratore Delegato | 01/02/2013 |
Precedenti posizioni note di Yoshihiro Arai
| Società | Posizione | Fine |
|---|---|---|
| Searle Yakuhin KK | Corporate Officer/Principal | - |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Corporate Officer/Principal | - |
Formazione di Yoshihiro Arai
| University of Wales (Bangor) | Masters Business Admin |
| Tokyo University of Pharmacy & Life Science | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SOLASIA PHARMA K.K. | Health Technology |
| Aziende private | 2 |
|---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
| Searle Yakuhin KK |
- Borsa valori
- Insiders
- Yoshihiro Arai